KCNJ8 encodes Kir6.1, a subunit of ATP-sensitive potassium (K-ATP) channels that exhibits inward rectifying properties, allowing greater potassium influx than efflux 1. The channel is activated by internal ATP depletion and blocked by external barium, with voltage dependence regulated by extracellular potassium concentration 1. KCNJ8 forms functional K-ATP channels with ABCC9 (SUR2) subunits, creating the predominant K-ATP conductance in vascular smooth muscle 1. The gene is preferentially expressed in human heart and localizes to chromosome 12 23. Functionally, KCNJ8-containing channels regulate brain vascular smooth muscle cell differentiation through modulation of intracellular calcium oscillations, which is essential for proper neurovascular coupling and cerebral blood flow control 4. Disease relevance includes Cantú syndrome, caused by gain-of-function mutations in KCNJ8 that result in multisystemic disorders characterized by hypertrichosis, macrocephaly, cardiomegaly, and vascular anomalies 56. Additionally, KCNJ8 mutations are associated with cardiac arrhythmias, including Brugada and early repolarization syndromes, where the S422L mutation causes reduced ATP sensitivity and incomplete channel closure 7. Clinical significance lies in potential therapeutic targeting with K-ATP channel inhibitors like glibenclamide for treating associated pathologies 1.